Universe Pharmaceuticals Stock Today
| UPC Stock | USD 0.45 0.07 13.46% |
Performance0 of 100
| Odds Of DistressOver 61
|
Universe Pharmaceuticals is trading at 0.45 as of the 30th of January 2025, a 13.46 percent decrease since the beginning of the trading day. The stock's open price was 0.52. Universe Pharmaceuticals has more than 61 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 2nd of October 2024 and ending today, the 30th of January 2025. Click here to learn more.
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited. The company has 2.1 M outstanding shares of which 159.9 K shares are at this time shorted by investors with about 0.11 days to cover. More on Universe Pharmaceuticals
Moving against Universe Stock
| 0.51 | MLAB | Mesa Laboratories Earnings Call This Week | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Universe Stock Highlights
| Old Name | UPC |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
| Financial Strength | |
Universe Pharmaceuticals (UPC) is traded on NASDAQ Exchange in USA. It is located in 265, Jingjiu Avenue, Ji'An, China, 343100 and employs 225 people. Universe Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a total capitalization of 1.09 M. Universe Pharmaceuticals runs under Biotechnology sector within Health Care industry. The entity has 2.1 M outstanding shares of which 159.9 K shares are at this time shorted by investors with about 0.11 days to cover.
Universe Pharmaceuticals has about 28.58 M in cash with 1.12 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Universe Pharmaceuticals Probability Of Bankruptcy
Ownership Allocation30% of Universe Pharmaceuticals outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change.
Check Universe Ownership Details
Universe Pharmaceuticals Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Universe Pharmaceuticals market risk premium is the additional return an investor will receive from holding Universe Pharmaceuticals long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.78) | |||
| Total Risk Alpha | (3.65) | |||
| Treynor Ratio | 0.9778 |
Universe Stock Against Markets
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universe Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Universe Pharmaceuticals. If investors know Universe will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Universe Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Universe Pharmaceuticals is measured differently than its book value, which is the value of Universe that is recorded on the company's balance sheet. Investors also form their own opinion of Universe Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Universe Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Universe Pharmaceuticals' market value can be influenced by many factors that don't directly affect Universe Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Universe Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Universe Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Universe Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.